site logo

Old market, new growth: Medtronic and Axonics competition ups sacral neuromodulation's reach

In a challenging year for elective procedures, Medtronic estimates a pelvic health market that's grown in the mid-single digits for the last 25 years increased 20% this past quarter.

Courtesy of Medtronic